← Back to Search

Fabric

DermaTherapy® Linen group for Pressure Sores

N/A
Waitlist Available
Led By Kenneth E Schmader, MD
Research Sponsored by Precision Fabrics Group, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly for 8 weeks
Awards & highlights

Study Summary

The primary purpose of this research study is to evaluate if DermaTherapy® bedding will significantly reduce pressure ulcer incidence by decreasing maceration, friction, and shearing among residents of Nursing Homes.

Eligible Conditions
  • Pressure Sores

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weekly for 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and weekly for 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Prevention and reduction in the incidence of pressure ulcers
Secondary outcome measures
Reduction of bacterial contamination

Trial Design

1Treatment groups
Experimental Treatment
Group I: DermaTherapy® Linen groupExperimental Treatment1 Intervention
The DermaTherapy® Linen group uses bed sheets and underpads made with DermaTherapy® fabric.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
DermaTherapy® Linen and underpads.
2010
N/A
~80

Find a Location

Who is running the clinical trial?

Precision Fabrics Group, Inc.Lead Sponsor
3 Previous Clinical Trials
3,458 Total Patients Enrolled
US Department of Veterans AffairsFED
868 Previous Clinical Trials
487,815 Total Patients Enrolled
Kenneth E Schmader, MDPrincipal InvestigatorDurham VA medical Center, Duke University Medical Center
1 Previous Clinical Trials
75 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025